S&P 500 Futures
(0.11%) 5 333.25 points
Dow Jones Futures
(0.07%) 40 166 points
Nasdaq Futures
(0.17%) 18 668 points
Oil
(0.25%) $80.26
Gas
(1.83%) $2.67
Gold
(0.98%) $2 441.00
Silver
(2.11%) $31.92
Platinum
(-0.41%) $1 085.50
USD/EUR
(-0.10%) $0.919
USD/NOK
(-0.03%) $10.67
USD/GBP
(0.00%) $0.787
USD/RUB
(0.07%) $91.04

Realtime updates for Valbiotis SA [ALVAL.PA]

Exchange: EURONEXT Industry: Biotechnology
Last Updated17 May 2024 @ 11:35

-2.48% 4.13

Live Chart Being Loaded With Signals

Commentary (17 May 2024 @ 11:35):

Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension...

Stats
Today's Volume 46 114.00
Average Volume 31 380.00
Market Cap 65.09M
EPS €0 ( 2024-04-28 )
Last Dividend €0 ( N/A )
Next Dividend €0 ( N/A )
P/E -6.99
ATR14 €0.00800 (0.20%)

Volume Correlation

Long: -0.05 (neutral)
Short: -0.65 (weak negative)
Signal:(55.566) Neutral

Valbiotis SA Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Valbiotis SA Correlation - Currency/Commodity

The country flag 0.45
( neutral )
The country flag 0.43
( neutral )
The country flag 0.00
( neutral )
The country flag 0.31
( neutral )
The country flag 0.00
( neutral )
The country flag -0.18
( neutral )

Valbiotis SA Financials

Annual 2023
Revenue: €4.73M
Gross Profit: €2.00M (42.26 %)
EPS: €-0.590
FY 2023
Revenue: €4.73M
Gross Profit: €2.00M (42.26 %)
EPS: €-0.590
FY 2022
Revenue: €785 000
Gross Profit: €767 000 (97.71 %)
EPS: €-1.220
FY 2021
Revenue: €2.05M
Gross Profit: €1.63M (79.64 %)
EPS: €-0.0828

Financial Reports:

No articles found.

Valbiotis SA Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Valbiotis SA

Valbiotis SA engages in the research and development of health nutrition products to prevent and combat metabolic and cardiovascular diseases. The company develops TOTUM-63 that is in Phase II/III clinical trials for the treatment of type 2 diabetes; TOTUM-070, which is in Phase II clinical trials to treat hypercholesterolemia; and TOTUM-854 that is in Phase II/III clinical trials for arterial hypertension. It also develops TOTUM-448 for the treatment of patient with non-alcoholic fatty liver disease. It has a strategic partnership with Nestlé Health Science. Valbiotis SA was incorporated in 2014 and is headquartered in Périgny, France.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators